Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQJKS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,071
Award facts
- Contract value 100% obligated
- $37,071.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $37,071.06 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of pharmaceutical products and medical supplies to the Defense Logistics Agency and other government healthcare systems. The company's federal contract awards demonstrate consistent capability in fulfilling competitive procurement requirements for brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains in support of military and veteran healthcare systems. This specific delivery order for RINVOQ ER tablets contributes to the company's broader mission of providing pharmaceutical support to Defense Health Agency and other federal health programs.
Quick answers
Who was awarded contract SPE2DB25FQJKS?
SPE2DB25FQJKS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FQJKS worth?
The government has obligated $37,071 on SPE2DB25FQJKS.
Is contract SPE2DB25FQJKS an order under another contract?
Yes. SPE2DB25FQJKS is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJKS competed?
The extent of competition for SPE2DB25FQJKS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award